-
Ocean Rig UDW Inc. (NASDAQ: ORIG) shares tumbled
54.4 percent to $0.985. Ocean Rig reported Q2 EPS $1.83 versus estimates of $0.72. Sales were $452.6 million versus estimates
of $376.45 million. During the call, Chairman and CEO George Economou assured the company will focus on de-leveraging and
maintaining liquidity, amidst “extremely negative” market conditions.
-
Concordia International Corp (NASDAQ: CXRX)
shares dipped 26.3 percent to $12.06 as the company announced second quarter earnings that missed the estimates. Aside from
that, the company slashed its forecast for the full year and suspended dividend.
-
Xtera Communications Inc (NASDAQ: XCOM) declined
21.3 percent to $0.890. Xtera Communications reported a Q3 loss of $1.35 per share on revenue of $5.3 million.
-
Superior Drilling Products, Inc. (NYSE: SDPI)
shares fell 14.9 percent to $1.20. Superior Drilling Products reported a Q2 loss of $0.18 per share, on revenue of $1.114
billion.
-
Aethlon Medical, Inc. (NASDAQ: AEMD) shares
dropped 12.9 percent to $6.59. Aethlon Medical reported a Q1 loss of $0.28 per share, versus a year-ago loss of $0.18 per
share.
-
Ruby Tuesday, Inc. (NYSE: RT) shares declined 12.7
percent to $3.26 as the company posted weaker-than-expected earnings for its fourth quarter and announced plans to close around
95 underperforming restaurants.
-
Crossroads Capital Inc (NASDAQ: XRDC) fell 11.8
percent to $2.06 as the company reported the filing of its quarterly report on Form 10-Q.
-
Voxeljet AG (ADR) (NYSE: VJET) shares dropped 10.8
percent to $4.42. voxeljet reported a Q2 loss of EUR 0.46 per share on sales of kEUR 6,296. The company also lowered its full
year 2016 revenue outlook.
-
Applied DNA Sciences Inc (NASDAQ: APDN) shares
fell 9.7 percent to $2.77. Applied DNA Sciences reported a Q3 loss of $0.14 per share on revenue of $653,000.
-
Payment Data Systems, Inc. (NASDAQ: PYDS)
declined 9.4 percent to $1.54. Payment Data Systems reported a Q2 loss of $0.05 per share on revenue of $2.9 million.
-
Pernix Therapeutics Holdings Inc (NASDAQ: PTX)
fell 8 percent to $0.700. Pernix Therapeutics reported a Q2 loss of $0.47 per share on revenue of $36.746 million. Brean
Capital downgraded Pernix Therapeutics from Buy to Hold.
-
Amedica Corporation (NASDAQ: AMDA) shares dropped
8 percent to $0.690. Amedica reported a Q2 loss of $0.40 per share on revenue of $4.02 million.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.